MCID: HMH002
MIFTS: 45

Hemihypertrophy malady

Fetal diseases, Cancer diseases, Rare diseases categories

Aliases & Classifications for Hemihypertrophy

About this section
Sources:
51Orphanet, 24GTR, 47Novoseek, 28ICD10 via Orphanet, 66UMLS via Orphanet
See all sources

Aliases & Descriptions for Hemihypertrophy:

Name: Hemihypertrophy 51 24 47
Hemicorporal Hypertrophy 51
 
Isolated Hemihyperplasia 51
Hemi 3 Syndrome 51


Classifications:



External Ids:

Orphanet51 2128
ICD10 via Orphanet28 Q87.3
UMLS via Orphanet66 C0332890

Summaries for Hemihypertrophy

About this section
Wikipedia:68 Hemihypertrophy, now more commonly referred to as Hemihyperplasia in the medical literature, is a... more...

MalaCards based summary: Hemihypertrophy, also known as hemicorporal hypertrophy, is related to monomelic amyotrophy and congenital nervous system abnormality, and has symptoms including asymmetric rib cage/thorax, scoliosis and asymmetry of the body/hemiatrophy/hemihyperthrophy. An important gene associated with Hemihypertrophy is H19 (H19, Imprinted Maternally Expressed Transcript (Non-Protein Coding)), and among its related pathways are Development IGF-1 receptor signaling and Glioblastoma Multiforme. Affiliated tissues include kidney, testes and liver, and related mouse phenotypes are renal/urinary system and normal.

Related Diseases for Hemihypertrophy

About this section

Diseases related to Hemihypertrophy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 257)
idRelated DiseaseScoreTop Affiliating Genes
1monomelic amyotrophy30.1ABCC8, KCNJ11
2congenital nervous system abnormality29.9IGF2, WT1
3beckwith-wiedemann syndrome29.1ABCC8, CDKN1C, H19, IGF2, KCNQ1OT1, SMPD1
4wilms tumor susceptibility-529.1CDKN1C, H19, IGF2, KCNQ1OT1, WT1
5medullary sponge kidney10.4
6hypoinsulinemic hypoglycemia with hemihypertrophy10.4
7hemimegalencephaly10.4
8proteus syndrome, somatic10.3
9klippel-trenaunay-weber syndrome10.2
10aniridia10.2
11hypoglycemia of infancy, leucine-sensitive10.2ABCC8, KCNJ11
12hyperinsulinemic hypoglycemia, familial, 110.2ABCC8, KCNJ11
13diabetes mellitus, transient neonatal 210.2ABCC8, KCNJ11
14atypical autism10.2ABCC8, KCNJ11
15trichodysplasia - amelogenesis imperfecta10.2ABCC8, KCNJ11
16fallopian tube adenocarcinoma10.2ABCC8, KCNJ11
17pheochromocytoma10.2
18cerebritis10.2
19adenoma10.2
20scoliosis10.2
21retinal telangiectasia10.2
22retinitis10.2
23acute insulin response10.2ABCC8, KCNJ11
24silver-russell syndrome due to maternal uniparental disomy of chromosome 1110.2H19, IGF2
25beckwith-wiedemann syndrome due to cdkn1c mutation10.2H19, IGF2
26diabetes mellitus, permanent neonatal10.1ABCC8, KCNJ11
27heart septal defect10.1PTEN, WT1
28cowden syndrome 610.1IGF2, PTEN
29focal dermal hypoplasia10.1
30hepatoblastoma10.1
31lipomatosis10.1
32rhabdomyosarcoma10.1
33hemi 3 syndrome10.1
34hemihypertrophy intestinal web corneal opacity10.1
35weber syndrome10.1
36vascular malformation10.1
37clapo syndrome10.1
38angioosteohypertrophic syndrome10.1
39hypoinsulinemic hypoglycemia and body hemihypertrophy10.1
40vagina squamous papilloma10.1H19, IGF2
41glucosephosphate dehydrogenase deficiency10.1ABCC8, AKT2, KCNJ11
42wilms tumor 210.1CDKN1C, H19
43macrogyria, pseudobulbar palsy and mental retardation10.1CDKN1C, PTEN
44childhood leukemia10.1IGF2, WT1
45caroli disease10.1ABCC8, KCNJ11
46hyperinsulinemic hypoglycemia, familial, 210.0ABCC8, IGF2, KCNJ11
47endodermal sinus tumor10.0ABCC8, IGF2, KCNJ11
48fetal methimazole syndrome10.0H19, IGF2
49renal cell carcinoma10.0
50megalencephaly-capillary malformation-polymicrogyria syndrome, somatic10.0

Graphical network of the top 20 diseases related to Hemihypertrophy:



Diseases related to hemihypertrophy

Symptoms for Hemihypertrophy

About this section

Symptoms:

 51 (show all 14)
  • asymmetric rib cage/thorax
  • scoliosis
  • asymmetry of the body/hemiatrophy/hemihyperthrophy
  • facial structural asymmetry/facial hemiatrophy/facial hemihypertrophy
  • abnormal dentition/dental position/implantation/unerupted/dental ankylosis
  • intellectual deficit/mental/psychomotor retardation/learning disability
  • inguinal/inguinoscrotal/crural hernia
  • congenital cardiac anomaly/malformation/cardiopathy
  • bladder and ureter anomalies
  • undescended/ectopic testes/cryptorchidia/unfixed testes
  • myelomeningocele
  • areflexia/hyporeflexia
  • insensitivity to pain
  • nephroblastoma/wilms tumor

Drugs & Therapeutics for Hemihypertrophy

About this section

Drugs for Hemihypertrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Doxorubicinapproved, investigationalPhase 3152523214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
2
EtoposideapprovedPhase 3112733419-42-036462
Synonyms:
(-)-Etoposide
121471-01-0
136598-18-0
201594-04-9
33419-42-0
35317-32-9
4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside
4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside
4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin
4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside
4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside
51854-34-3
76576-58-4
9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one
AB00438905
AC1L1FN8
AC1L1VT3
AC1L6246
AC1NR4OG
AC1O4WGG
AC1O7M1N
AC1Q47JJ
Ambap33419-42-0
BPBio1_000673
BRD-K37798499-001-02-5
BSPBio_000611
Bio1_000489
Bio1_000978
Bio1_001467
C01576
CCRIS 2392
CHEBI:4911
CHEBI:588795
CHEMBL44657
CID11758093
CID284997
CID3310
CID36462
CID5284558
CID6419930
CID6610299
CPD000112002
D00125
DB00773
DEMETHY-EPIPODOPHYLLOTOXIN,ETHYLIDENE GLUCOSIDE,
Demethyl Epipodophyllotoxin Ethylidine Glucoside
Demethyl-epiodophyllotoxin ethylidene glucoside
Demethylepipodophyllotoxin-beta-D-ethylideneglucoside
E0675
E1383_SIGMA
EINECS 251-509-1
EPE
EPEG
ETOP
Epipodophyllotoxin
Epipodophyllotoxin VP-16213
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI)
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside)
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
Eposide
Eposin
Eposin, Vepesid, VP-16, Toposar, Etoposide
 
Etopol
Etopophos
Etopophos (phosphate salt)
Etoposid
Etoposide
Etoposide (JP15/USP/INN)
Etoposide (VP16)
Etoposide Phosphate
Etoposide [USAN:INN:BAN:JAN]
Etoposido
Etoposido [INN-Spanish]
Etoposidum
Etoposidum [INN-Latin]
Etosid
HMS1569O13
HMS2052N05
HMS2089F14
HSDB 6517
I06-0248
KBioSS_002410
LS-1214
Lastet
MLS000049957
MLS001074951
MLS001424283
MLS002153463
MLS002207239
MLS002222184
MolPort-003-983-431
MolPort-004-905-001
MolPort-004-955-161
NCGC00025056-02
NChemBio.2007.10-comp19
NK 171
NSC 141540
NSC-141540
NSC141540
Prestwick0_000396
Prestwick1_000396
Prestwick2_000396
Prestwick3_000396
Prestwick_211
S1225_Selleck
SAM001246880
SMR000112002
SPBio_002532
ST056353
Toposar
UNII-6PLQ3CP4P3
VP 16
VP 16 (pharmaceutical)
VP 16-213
VP 16213
VP-16
VP-16-213
VePESID (TN)
VePesid
Vepesid
Vepesid J
Vepeside
ZINC03830818
ZINC03938684
Zuyeyidal
etoposide
nchembio.573-comp8
nchembio873-comp2
trans-Etoposide
3
CarboplatinapprovedPhase 3181241575-94-410339178, 498142, 38904, 38904, 498142
Synonyms:
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
/h1-3H2,(H,7,8)(H,9,10)
/q
1,1-Cyclobutanedicarboxylate diammine platinum (II)
1,1-Cyclobutanedicarboxylate diammine platinum(II)
2*-1
2*1H2
41575-94-4
70903-55-8
AC-1457
AC1L8I6U
Ambap41575-94-4
BSPBio_003145
C 2538
C2043
C2538_SIGMA
C6H10N2O4Pt
CBDCA
CCRIS 3404
CHEBI:31355
CHEMBL1351
CHEMBL288376
CID10339178
CID2567
CID38904
CID426756
CID498142
CID5352133
CID6398587
CID6603770
Carbopaltin
Carboplatin
Carboplatin (JAN/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Cbdca
Cyclobutane-1,1-dicarboxylate
D01363
DB00958
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
DivK1c_000892
EINECS 255-446-0
EU-0100230
Ercar
HMS1921J16
HMS2090M05
HMS2092B22
HMS502M14
HSDB 6957
I14-2390
IDI1_000892
IUPAC: Azane
InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6
 
JM 8
JM-8
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
LS-117689
Lopac-C-2538
Lopac0_000230
MolPort-003-665-501
MolPort-003-845-609
NCGC00015223-01
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NINDS_000892
NSC 201345
NSC 241240
NSC-241240
NSC201345
NSC241240
Paraplatin
Paraplatin (TN)
Paraplatin, Carboplatin
Paraplatin-AQ
Platinum(+2) Cation
Platinum(II), (1, 1-cyclobutanedicar
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, {diammine[1,1-cyclobut
S1215_Selleck
SPBio_000716
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
Spectrum_001529
UNII-BG3F62OND5
azanide
carboplatin
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii)
cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cyclobutane-1,1-dicarboxylic acid
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
nchembio.573-comp10
nchembio773-comp2
nchembio873-comp3
platinum(2+)
4
DactinomycinapprovedPhase 34650-76-02019, 457193
Synonyms:
(- )-actinomycin d
(-)-actinomycin d
-pentone
01815_FLUKA
1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine
2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-I)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide
4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide
50-76-0
A1410_SIGMA
A4262_SIGMA
A9415_SIGMA
AC1L1CQX
AC1L9W52
ACT
ACT D
ACTINOMYCIN D
ACTINOMYCIN D AMP
ACTINOMYCIN-D
ACTO-D
ACon0_000471
ACon1_001004
AD
AD (VAN)
AI3-26374
ActD
Actactinomycin A IV
Actactinomycin a Iv
Actinomycin 11 Cosmegen
Actinomycin 11 cosmegen
Actinomycin 7
Actinomycin A IV
Actinomycin Aiv
Actinomycin C (sub1)
Actinomycin C(sub1)
Actinomycin C1
Actinomycin D
Actinomycin D (JP15)
Actinomycin D deriv. of 3H-phenoxaocardazine
Actinomycin D, sodium deoxyribonucleic acid complex
Actinomycin I
Actinomycin I (sub1)
Actinomycin I(sub 1)
Actinomycin I(sub1)
Actinomycin I1
Actinomycin IV
Actinomycin Iv
Actinomycin X 1
Actinomycin X1
Actinomycin iv
Actinomycin-(threo-val-pro-sar-meval)
Actinomycin-?IV
Actinomycin-[threo-val-pro-sar-meval]
Actinomycindioic D Acid, Dilactone
Actinomycindioic D acid, dilactone
Acto-D
Antibiotic From Streptomyces Parvullus
Antibiotic from Streptomyces parvullus
BCBcMAP01_000155
BRD-A42383464-001-02-2
Bio1_000342
Bio1_000831
Bio1_001320
C06770
C1
C62H86N12O16
CBiol_002056
CCRIS 9
CHEBI:123721
CHEBI:27666
CHEMBL1554
CHEMBL427947
CID2019
 
CID457193
COSMEGEN (TN)
CPD000469227
Chounghwamycin B
Cosmegen
D Actinomycin
D00214
DACTINOMYCIN
DB00970
DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA
Dactinomicina
Dactinomicina [INN-Spanish]
Dactinomycin
Dactinomycin (USP)
Dactinomycin D
Dactinomycin [USAN:BAN]
Dactinomycine
Dactinomycine [INN-French]
Dactinomycinum
Dactinomycinum [INN-Latin]
Dilactone Actinomycin D Acid
Dilactone Actinomycindioic D Acid
Dilactone actin omycindioic D acid
Dilactone actinomycin D acid
Dilactone actinomycindioic D acid
EINECS 200-063-6
FT-0080366
GNF-PF-1977
HBF 386
HBF 386 Meractinomycin
HBF 386 meractinomycin
HMS2052O17
HSDB 3220
LMPK14000005
LS-142
Lyovac Cosmegen
Lyovac cosmegen
MEGxm0_000350
MLS001424196
Meractinomycin
MolPort-001-739-741
MolPort-003-925-177
NCGC00025059-02
NCGC00090796-01
NCGC00161622-01
NCGC00161622-02
NCGC00169767-01
NCI-C04682
NCI60_030539
NP-005932
NSC 3053
NSC-3053
NSC191297
NSC3053
Neuro_000003
Oncostatin K
Oxamide
PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA
SAM001246846
SMP1_000005
SMR000469227
UNII-1CC1JFE158
UPCMLD-DP055
UPCMLD-DP055:001
UPCMLD-DP055:002
WLN: 16- AN FVN IVN LVO PVM SVTJ G1 J1 KY1&1 N1 RY1&1
X 97
actd
actinomycin D
actinomycin cl
actinomycin x i
actinomyein-theo-val-pro-sar-meval
dactinomyein d
o)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine
5
Cyclophosphamideapproved, investigationalPhase 3252550-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
 
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
6
Vincristineapproved, investigationalPhase 38362068-78-2, 57-22-75978
Synonyms:
22-Oxovincaleukoblastin
22-Oxovincaleukoblastine
28379-27-3
57-22-7
AC1L1LJC
C07204
C46H56N4O10
CCRIS 5763
CHEBI:28445
CID5978
D08679
DB00541
EINECS 200-318-1
HMS2090E19
HSDB 3199
Indole alkaloid
LCR
LS-228
Leurocristine
Lilly 37231 (1:1 sulfate salt)
Liposomal Vincristine
Marqibo
NCGC00163700-01
NCI-C04864
NCI60_026703
NSC-67574
Onco TCS
 
Oncovin
Oncovin (1:1 sulfate salt)
Oncovine
Tecnocris
Tecnocris (TN)
UNII-5J49Q6B70F
VCR
VIN
Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine
Vincasar
Vincasar (1:1 sulfate salt)
Vincasar PFS
Vincrex
Vincrex (1:1 sulfate salt)
Vincristin
Vincristina
Vincristina [DCIT]
Vincristine (INN)
Vincristine Sulfate
Vincristine Sulfate PFS
Vincristine [INN:BAN]
Vincristinum
Vincristinum [INN-Latin]
Vincrstine
Vincrystine
Vinkristin
Z-D-Val-Lys(Z)-OH
vincristine
7
DoxilApproved June 1999Phase 3152531703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
8Etoposide phosphatePhase 31127

Interventional clinical trials:

idNameStatusNCT IDPhase
1Combination Chemotherapy and Surgery in Treating Young Patients With Wilms TumorSuspendedNCT00945009Phase 3
2Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary AnomaliesRecruitingNCT00503893

Search NIH Clinical Center for Hemihypertrophy

Genetic Tests for Hemihypertrophy

About this section

Genetic tests related to Hemihypertrophy:

id Genetic test Affiliating Genes
1 Hemihypertrophy24

Anatomical Context for Hemihypertrophy

About this section

MalaCards organs/tissues related to Hemihypertrophy:

33
Kidney, Testes, Liver, Bone, Heart, Cervix, Skin

Animal Models for Hemihypertrophy or affiliated genes

About this section

MGI Mouse Phenotypes related to Hemihypertrophy:

38 (show all 15)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053678.5CDKN1C, IGF2, KCNQ1OT1, PTEN, WT1
2MP:00028738.3AKT2, CDKN1C, H19, KCNQ1OT1, PTEN, WT1
3MP:00030128.2ABCC8, AKT2, H19, IGF2, KCNJ11, WT1
4MP:00053808.2CDKN1C, H19, IGF2, KCNQ1OT1, PTEN, WT1
5MP:00053698.0AKT2, CDKN1C, IGF2, KCNJ11, PTEN, WT1
6MP:00053708.0AKT2, IGF2, KCNQ1OT1, PTEN, SMPD1, WT1
7MP:00036317.6AKT2, CDKN1C, H19, IGF2, KCNJ11, PTEN
8MP:00053887.3AKT2, CDKN1C, IGF2, KCNQ1OT1, PTEN, SMPD1
9MP:00053847.3AKT2, CDKN1C, H19, IGF2, KCNQ1OT1, PTEN
10MP:00053897.3AKT2, CDKN1C, IGF2, PTEN, SMPD1, WT1
11MP:00053797.2ABCC8, AKT2, CDKN1C, IGF2, KCNJ11, PTEN
12MP:00107686.6AKT2, CDKN1C, H19, IGF2, KCNJ11, KCNQ1OT1
13MP:00053786.6AKT2, CDKN1C, H19, IGF2, KCNJ11, KCNQ1OT1
14MP:00053766.5ABCC8, AKT2, CDKN1C, IGF2, KCNJ11, PTEN

Publications for Hemihypertrophy

About this section

Articles related to Hemihypertrophy:

(show top 50)    (show all 228)
idTitleAuthorsYear
1
Specimens from a Case of Right-sided Hemihypertrophy associated with Pubertas PrA (20914695)
cox.
2
Beckwith-Wiedemann syndrome and Chiari I malformation-a case-based review of central nervous system involvement in hemihypertrophy syndromes. (25686896)
2015
3
Recurrent benign adrenal pheochromocytomas associated with hemihypertrophy. (25136447)
2014
4
Letter to the editor: Pseudopapillary tumor of the pancreas in a child with hemihypertrophy and a history of Wilms tumor. (24962628)
2014
5
Phakomatosis pigmentovascularis Ib with left-sided hemihypertrophy, interdigital gaps and scoliosis: a unique case of phakomatosis pigmentovascularis. (23039104)
2013
6
WT1 expression and hemihypertrophy in congenital mesoblastic nephroma. (19011477)
2008
7
A female with hemihypertrophy and chylous ascites - Klippel-Trenaunay syndrome or Proteus syndrome: a diagnostic dilemma. (16957479)
2006
8
Differences in dental and bone maturation in regions with or without hemihypertrophy in two patients with Russell-Silver syndrome. (16128247)
2005
9
Congenital hemihypertrophy with hemihypertrichosis. (16043924)
2005
10
Children with idiopathic hemihypertrophy and beckwith-wiedemann syndrome have different constitutional epigenotypes associated with wilms tumor. (16252245)
2005
11
A 4-month-old girl with hemihypertrophy. (15792108)
2005
12
Hypoketotic hypofattyacidaemic hypoinsulinaemic hypoglycaemia in a child with hemihypertrophy? A new syndrome. (14764948)
2004
13
Presence of vascular anomalies with congenital hemihypertrophy and Wilms tumor: an evidence-based evaluation. (12787266)
2003
14
Netherton syndrome associated with idiopathic congenital hemihypertrophy. (12220283)
2002
15
Mosaic trisomy 15 and hemihypertrophy. (11694227)
2001
16
A child with adrenocortical adenoma accompanied by congenital hemihypertrophy: report of a case. (11039721)
2000
17
Hemihypertrophy and a poorly differentiated embryonal rhabdomyosarcoma of the pelvis. (9917751)
1999
18
What syndrome is this? Epidermal nevus syndrome: a neurologic variant with hemimegalencephaly, facial hemihypertrophy and gyral malformation. (9496809)
1998
19
Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. (9781907)
1998
20
A case of craniofacial dysmorphism, congenital heart defects, coccygeal skin folds, generalized skeletal alterations, and hemihypertrophy with linear skin hypopigmentation: a new syndrome? (9610002)
1998
21
Nevus depigmentosus associated with hemihypertrophy of the limbs. (7501569)
1995
22
Hemimegalencephaly, hemihypertrophy and vascular lesions. (7720742)
1995
23
Cranial hemihypertrophy with ipsilateral naevoid streaks, intellectual handicap and epilepsy: a report of two cases. (8313622)
1993
24
Twelve cases with hemihypertrophy: etiology and follow up. (8357562)
1993
25
Cystic adrenal masses in the neonate associated with hemihypertrophy and the relation to the Beckwith-Wiedemann syndrome. (1861304)
1991
26
Cranial hemihypertrophy and neurodevelopmental prognosis. (2325089)
1990
27
Epidermal nevus syndrome with hemimegalencephaly: a clinical report of a case with acanthosis nigricans-like nevi on the face and neck, hemimegalencephaly, and hemihypertrophy of the body. (2751068)
1989
28
Adrenocortical carcinoma in a child with congenital hemihypertrophy. (2750343)
1989
29
Partial nephrectomy for Wilms' tumor in a child with hemihypertrophy. (2982085)
1985
30
Infantile idiopathic scoliosis in hemihypertrophy with haemangiomatosis. (6094802)
1984
31
Hemimegalencephaly with hemihypertrophy (Klippel-TrAcnaunay-Weber syndrome). (6310854)
1983
32
A thoracic benign mesenchymoma in association with hemihypertrophy. (6274186)
1981
33
Familial facial asymmetry (autosomal dominant hemihypertrophy?). (6935582)
1980
34
Two cases of Beckwith-Wiedemann syndrome, one with hemihypertrophy. (6932218)
1980
35
Hemihypertrophy with unilateral folliculitis and acne. (161466)
1979
36
Unilateral hydrocephalus associated with congenital hemihypertrophy. (77494)
1978
37
Myeloblastic leukemia and congenital hemihypertrophy. (192872)
1977
38
Macrodactyly, hemihypertrophy, and connective tissue nevi: report of a new syndrome and review of the literature. (993918)
1976
39
Hemihypertrophy in a boy with renal polycystic disease: varied patterns of presentation of renal polycystic disease in his family. (1012806)
1976
40
Congenital asymmetry (hemihypertrophy) and abdominal disease: radiological features in 9 cases. (168617)
1975
41
Wilms's tumor in three children of a woman with congenital hemihypertrophy. (4364969)
1974
42
Congenital heart disease in congenital hemihypertrophy. (5141736)
1971
43
Congenital hemihypertrophy with neurofibromatosis. (4978359)
1969
44
Congenital partial hemihypertrophy of the face. Report of three cases. (5241846)
1968
45
Congenital hemihypertrophy. Report of two cases and review of the literature. (5938488)
1966
46
Congenital hemihypertrophy and malignancy. (13967519)
1963
47
Congenital hemihypertrophy. Review of the literature and report of a case with special emphasis on oral manifestations. (13949299)
1962
48
Hemihypertrophy left side of body; congenital lymphatic oedema of left arm; radiological enlargement of heart shadow. (14395215)
1955
49
A review of the subject of congenital hemihypertrophy and a complete case report. (20265776)
1947
50
Hemihypertrophy. (19972767)
1908

Variations for Hemihypertrophy

About this section

Expression for genes affiliated with Hemihypertrophy

About this section
Search GEO for disease gene expression data for Hemihypertrophy.

Pathways for genes affiliated with Hemihypertrophy

About this section

Pathways related to Hemihypertrophy according to GeneCards Suite gene sharing:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
9.4AKT2, IGF2, PTEN
29.4AKT2, IGF2, PTEN
39.2ABCC8, AKT2, KCNJ11
49.1AKT2, PTEN, SMPD1

GO Terms for genes affiliated with Hemihypertrophy

About this section

Biological processes related to Hemihypertrophy according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of glycogen biosynthetic processGO:004572510.4AKT2, IGF2
2protein kinase B signalingGO:004349110.0AKT2, PTEN
3negative regulation of insulin secretionGO:00466769.9ABCC8, KCNJ11
4response to zinc ionGO:00100439.8ABCC8, PTEN
5adrenal gland developmentGO:00303259.6CDKN1C, WT1
6response to ATPGO:00331989.5KCNJ11, PTEN
7glucose metabolic processGO:00060069.4AKT2, IGF2, KCNJ11
8response to drugGO:00424938.2ABCC8, KCNJ11, PTEN, SMPD1

Sources for Hemihypertrophy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet